Faiz Ramjankhan

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 5

Top Topics

Atrial Fibrillation

Physical Activity

Cardiovascular Events

Top Venues

Journal of the American Heart Association

This page only lists publications with an associated author ORCID identifier.

Publications

Lieke Numan, Emmeke Aarts, Faiz Ramjankhan, Marish I F J Oerlemans, Manon G van der Meer, Nicolaas de Jonge, Anne-Marie Oppelaar, Hans Kemperman, Folkert W. Asselbergs, Linda W Van Laake
Soluble Suppression of Tumorigenicity-2 Predicts Mortality and Right Heart Failure in Patients With a Left Ventricular Assist Device. Journal of the American Heart Association 13 (2) (2024)
Lieke Numan, Emmeke Aarts, Faiz Ramjankhan, Marish I F J Oerlemans, Manon G van der Meer, Nicolaas de Jonge, Anne-Marie Oppelaar, Hans Kemperman, Folkert W. Asselbergs, Linda W Van Laake
Soluble Suppression of Tumorigenicity-2 Predicts Mortality and Right Heart Failure in Patients With a Left Ventricular Assist Device. Journal of the American Heart Association 13 (2) (2024)
Lieke Numan, Emmeke Aarts, Faiz Ramjankhan, Marish I F J Oerlemans, Manon G van der Meer, Nicolaas de Jonge, Anne-Marie Oppelaar, Hans Kemperman, Folkert W. Asselbergs, Linda W Van Laake
Soluble Suppression of Tumorigenicity-2 Predicts Mortality and Right Heart Failure in Patients With a Left Ventricular Assist Device. Journal of the American Heart Association 13 (2) (2024)
Lieke Numan, Emmeke Aarts, Faiz Ramjankhan, Marish I F J Oerlemans, Manon G van der Meer, Nicolaas de Jonge, Anne-Marie Oppelaar, Hans Kemperman, Folkert W. Asselbergs, Linda W Van Laake
Soluble Suppression of Tumorigenicity-2 Predicts Mortality and Right Heart Failure in Patients With a Left Ventricular Assist Device. Journal of the American Heart Association (2024)
Lieke Numan, Emmeke Aarts, Faiz Ramjankhan, Marish I F J Oerlemans, Manon G van der Meer, Nicolaas de Jonge, Anne-Marie Oppelaar, Hans Kemperman, Folkert W. Asselbergs, Linda W Van Laake
Soluble Suppression of Tumorigenicity-2 Predicts Mortality and Right Heart Failure in Patients With a Left Ventricular Assist Device. Journal of the American Heart Association 13 (2) (2024)